Quantcast

Latest Oncology Stories

2014-06-03 12:39:11

LIVERMORE, Calif., June 3, 2014 /PRNewswire/ -- Halt Medical, Inc., today announced that Aetna US Healthcare and Coventry Health Care have published updates to their Fibroid Treatment Clinical Policy and are now providing benefits for Halt Medical's Acessa(TM) Procedure as a treatment option for women with symptomatic uterine fibroids. http://photos.prnewswire.com/prnvar/20131202/LA26268LOGO Aetna US Healthcare is the third largest national commercial insurer in the United States...

2014-06-03 12:27:34

Institute of Cancer Research Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime, a large-scale, international study reveals. Scientists announce a previously unknown link between lung cancer and a particular BRCA2 defect, occurring in around 2 per cent of the population, in research published in Nature Genetics today (Sunday). The defect in BRCA2 - best known for its role in breast cancer - increases the risk of...

2014-06-03 12:15:53

Yale University A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. Yale Cancer Center played a key role in the study, the results of which will be presented Saturday, May 31 at the 2014 annual conference of the American Society of Clinical Oncology (ASCO) in Chicago. The trial included 68 people with previously...

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...

2014-06-03 08:32:24

Two Studies Presented at ASCO® Demonstrate Company's Ability to Develop Tests to Predict Disease Aggressiveness Across Various Cancers REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of two studies demonstrating the ability of its Oncotype DX(®) test and a new 16-gene panel to predict disease aggressiveness and clinical outcomes in prostate and renal cancers, respectively. These results, presented at the American...

2014-06-03 08:31:55

OTTAWA, June 3, 2014 /CNW/ - The Canadian Dermatology Association (CDA) is challenging young people across Canada to put their creativity to work and make a short video about sun safety as part of National Sun Awareness Week, June 2(nd) - 8(th). This is the third year the CDA is hosting the Sun. Camera. Action. video contest and hopes to see many more great videos. "Getting young people involved in awareness efforts for sun safety is essential," says Dr. Cheryl Rosen, National...

2014-06-02 23:02:35

Key West, Fla. resident Michele White explains her battle with skin cancer and treatment with 21st Century Oncology. Key West, FL (PRWEB) June 02, 2014 When 43-year-old Capital Bank Vice President Michele White first noticed an unusual growth on her upper lip, she thought it was just acne or a minor irritation from being out in the sun. A few weeks passed and it didn’t go away, so she visited her dermatologist to get it checked. After an initial appointment and biopsy, White was...

2014-06-02 16:26:36

LONDON, June 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Vulvar Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/vulvar_cancer_global_clinical_trials_review.html Vulvar Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Vulvar Cancer Global Clinical Trials Review, H1, 2014" provides data on the Vulvar Cancer clinical trial scenario. This...

2014-06-02 16:26:24

OAKLAND, Calif., June 2, 2014 /PRNewswire/ -- Patients with specific HER2+ breast cancer tumors have a low risk of the cancer recurring five years after diagnosis, even without chemotherapy or treatment with a common antibody, according to a Kaiser Permanente study published in the Journal of Clinical Oncology. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO Researchers reviewed 16,975 cases of breast cancer diagnosed in Kaiser Permanente patients between 2000 and 2006....

2014-06-02 16:25:16

Cancers characterized by DICER1 genetic defect are advancing new approach to cancer treatments, cures MINNEAPOLIS, June 2, 2014 /PRNewswire/ -- Recent findings by researchers from the International Pleuropulmonary Blastoma (PPB) Registry and International Ovarian and Testicular Stromal (OTST) Tumor Registry, both based at Children's Hospitals and Clinics of Minnesota, have advanced the potential for early diagnosis and proactive treatment of children in families affected by...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related